domingo, 29 de enero de 2017

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. - PubMed - NCBI

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. - PubMed - NCBI



 2017 Jan 20. doi: 10.1038/leu.2017.28. [Epub ahead of print]

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.

Abstract

Leukemia accepted article preview online, 20 January 2017. doi:10.1038/leu.2017.28.

PMID:
 
28104920
 
DOI:
 
10.1038/leu.2017.28

[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario